322 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
STRATEGY & GOVERNANCE Conducted a revised global ESG materiality assessment Expanded ESG operating model to further align with company strategy
424B5
BMY
Bristol-Myers Squibb Co.
16 Feb 24
Prospectus supplement for primary offering
4:34pm
assessment of the likelihood of timely payment of interest when due and the payment of principal on the maturity date. Any downgrade or withdrawal
424B2
i53fxtrgq7 ubw36x
13 Feb 24
Prospectus for primary offering
8:00am
SC TO-T
EX-99
jof0kntaig
25 Jan 24
Third party tender offer statement
8:13am
8-K
EX-99.1
lc6 950sw8a1
8 Jan 24
Regulation FD Disclosure
10:29am
424B5
1w682m95 9yxqn3wsk1f
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
0z551e2n fr
30 Oct 23
Prospectus supplement
8:05am
DFAN14A
wt2l0vqpd3zi
10 Oct 23
Additional proxy materials by non-management
6:48am